close
MENU
Hot Topic Summer features
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Summer features
Investment
5 mins to read

Pacific Edge shares tumble after US reimbursement blow

The company admits the Novitas decision is a ‘significant blow’ but says it’s not a knockout.

Pacific Edge chief executive Peter Meintjes.

Fiona Rotherham Mon, 13 Jan 2025

Shares in NZX-listed cancer diagnostic company Pacific Edge have fallen about 55% since the lifting of a trading halt today following a decision against reimbursement for its Cxbladder tests for its largest customer, US Medicare.

Novitas, the Medicare Administrative Contractor (MAC) with

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Mon, 13 Jan 2025
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Pacific Edge Novitas Cxbladder Medicare
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
2

Pacific Edge will need to ‘batten down the hatches’, analyst says
Investment
1

Forbar sees Pacific Edge capital raise in next year
Investment
2

‘No comment’ from Pacific Edge on future capital raise
Investment
2

Pacific Edge board plots response to big US decision
Investment

Pacific Edge’s share price spikes
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
2

Pacific Edge will need to ‘batten down the hatches’, analyst says
Investment
1

Forbar sees Pacific Edge capital raise in next year
Investment
2

‘No comment’ from Pacific Edge on future capital raise
Investment
2

Pacific Edge board plots response to big US decision
Investment

Pacific Edge’s share price spikes
Pacific Edge shares tumble after US reimbursement blow
Investment,
107375
true
Subscribe Login